Financial News
Articles published by Alvotech
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Announces Webcast of 2022 Full Year Financial Results at 8:00 am ET on March 2, 2023
February 27, 2023
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Settlement of Alvotech Private Share Placement Completed
February 10, 2023
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
February 09, 2023
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Enters Into Commercialization Agreement With Advanz Pharma for Proposed Biosimilar to Xolair® (Omalizumab)
February 06, 2023
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia
January 24, 2023
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Completes $137 Million Private Share Placement
January 23, 2023
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Initiates Pharmacokinetic Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®
January 11, 2023
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Correction to Total Amount in Announcement About Private Placement Published 2022-12-16 09:00 GMT to headline field
December 16, 2022
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Completes $59.7 Million Private Placement
December 16, 2022
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Shares Start Trading on Nasdaq Iceland Main Market
December 08, 2022
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Announces Changes to its Leadership Team
December 01, 2022
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Secures Financing Facilities of Approximately $136 Million
November 16, 2022
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Reports Financial Results for First Nine Months of 2022 And Provides Business Update
November 16, 2022
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Announces Australian Marketing Authorization for AVT02, a Biosimilar to Humira®
November 14, 2022
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
October 26, 2022
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech’s Partner Submits Application for Marketing Approval of First Biosimilar Candidate in Japan
October 17, 2022
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://ml-eu.globenewswire.com/media/17a8091d-68a6-47c1-968e-fcced99f1d44/small/alvotech-logo-jpg.jpg)
Alvotech Appoints Sarah Tanksley as Chief Quality Officer
October 11, 2022
From Alvotech
Via GlobeNewswire
Tickers
ALVO
![](https://mms.businesswire.com/media/20220615006029/en/1347090/5/Alvotech_logo.jpg)
![](https://mms.businesswire.com/media/20220609005376/en/1347090/5/Alvotech_logo.jpg)
![](https://mms.businesswire.com/media/20211215005989/en/840370/5/Alvotech_logo_orange_grey.jpg)
![](https://mms.businesswire.com/media/20211007005933/en/840370/5/Alvotech_logo_orange_grey.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.